Zymeworks
ZYME • NASDAQ
Zymeworks is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Kenneth H. Galbraith, with a market cap of $2.0B.
Market Cap$2.0B
Employees275.0
CEOKenneth H. Galbraith
CountryCanada
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Zymeworks FAQ
Common questions about Zymeworks
Zymeworks is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $38.9M.
Zymeworks has approximately 275 employees.